These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Prophylaxis for acute gout flares after initiation of urate-lowering therapy. Latourte A; Bardin T; Richette P Rheumatology (Oxford); 2014 Nov; 53(11):1920-6. PubMed ID: 24758886 [TBL] [Abstract][Full Text] [Related]
13. Role of interleukin-1 inhibitors in the management of gout. Tran TH; Pham JT; Shafeeq H; Manigault KR; Arya V Pharmacotherapy; 2013 Jul; 33(7):744-53. PubMed ID: 23553601 [TBL] [Abstract][Full Text] [Related]
14. The emerging role of biotechnological drugs in the treatment of gout. Cavagna L; Taylor WJ Biomed Res Int; 2014; 2014():264859. PubMed ID: 24839602 [TBL] [Abstract][Full Text] [Related]
15. Pegloticase: a novel agent for treatment-refractory gout. Shannon JA; Cole SW Ann Pharmacother; 2012 Mar; 46(3):368-76. PubMed ID: 22395256 [TBL] [Abstract][Full Text] [Related]
16. Gout: an update. Eggebeen AT Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294 [TBL] [Abstract][Full Text] [Related]
17. Gout therapeutics: new drugs for an old disease. Burns CM; Wortmann RL Lancet; 2011 Jan; 377(9760):165-77. PubMed ID: 20719377 [TBL] [Abstract][Full Text] [Related]
18. Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors. Goldfarb DS; MacDonald PA; Hunt B; Gunawardhana L J Rheumatol; 2011 Jul; 38(7):1385-9. PubMed ID: 21572152 [TBL] [Abstract][Full Text] [Related]
19. Novel drug discovery strategies for gout. Richette P; Garay R Expert Opin Drug Discov; 2013 Feb; 8(2):183-9. PubMed ID: 23231400 [TBL] [Abstract][Full Text] [Related]
20. Pegloticase and the patient with treatment-failure gout. Dave AJ; Kelly VM; Krishnan E Expert Rev Clin Pharmacol; 2012 Sep; 5(5):501-8. PubMed ID: 23121270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]